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genetics, M. truncatula harbors
several attributes that make it
attractive as a model species. It
has a short seed-to-seed
generation time and abundant
seed set. Extensive collections of
M. truncatula ecotypes — natural
geographic variants — exist, and
mutant collections are readily
produced by physical (fast
neutron) and transposon-
mediated mutagenesis. M.
truncatula is also host to
Sinorhizobium meliloti, a
rhizobium species whose
genome has been fully
sequenced.
What resources are available
for M. truncatula research?
With almost 200,000 expressed
sequence tags (ESTs) and greater
than 85 Mb of genome sequence
currently deposited in publicly
available databases, legume
researchers have access to a rich
data set that outlines the gene
content of M. truncatula. In
addition, community-
standardized M. truncatula DNA
microarrays are available which
facilitate near global transcript
profiling. Many genes in M.
truncatula have over 98%
sequence identity with their
orthologs in alfalfa, and so the M.
truncatula microarrays can also
be used for expression profiling
of alfalfa. Collaborative research
programs are underway that
detail the transcript, protein and
metabolite profiles of M.
truncatula. A series of forward
and reverse genetics
methodologies and populations
have also been established.
Extensive bioinformatics
resources also exist which
facilitate data comparison within
M. truncatula and leverage the
data available for this model
species to other agronomically
important legume crop species.
Is there a M. truncatula
genome project? After
Arabidopsis and rice, M.
truncatula will be the next plant
to have its genome completely
sequenced. An international
Medicago sequencing project
has begun that involves
laboratories in the US, the UK
and France. It is anticipated that
sequencing the Medicago
genome will be completed within
the next three years. The genome
sequence of M. truncatula will
serve as a basis for structural
genomics comparisons with
other legume species such as
alfalfa and soybean.
Where can I find out more
about M. truncatula?
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‘Spalog’ and
‘sequelog’:
neutral terms for
spatial and
sequence
similarity
Alexander Varshavsky
Similarities amongst sequences or
three-dimensional (3-D) structures
and conjectures based on
similarities are a major topic of
molecular biology and related
fields. Therefore it is striking that
there are presently no terms that
denote a sequence or a 3-D
structure that is similar to another
sequence or 3-D structure without
implying anything at all about
evolutionary relatedness or
biological functions. The lack of
such neutral terms for denoting
similarity is one reason for the
widespread use of the terms
‘homolog’, ‘ortholog’ and
‘paralog’. The first term is more
than a century old and the other
two were proposed long before
the advent of extensive sequence
comparisons [1].
To state that a gene or a protein
A is a homolog of B implies that A
and B are related through common
descent, a proposition that needs
to be proven in most cases [2]. In
addition, two sequences can be
37% identical, but they cannot be
37% homologous — they are either
homologous or not. The frequent
unsuitability of the term ‘homolog’
in the context of similarity was
pointed out repeatedly [2,3], but
the literature is still rife with this
misuse, in part because proper
neutral terms simply do not exist.
The disposition can be also
difficult with the terms ‘ortholog’
and ‘paralog’. Orthologs are two
homologous sequences that
diverged following speciation,
such that the common precursor
of two sequences was harboured
by the last common ancestor of
the two species. Paralogs, by
contrast, are two homologous
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Figure 1. The model legume Medicago
truncatula.
The shape of M. truncatula seed pods
(top right) lead to its common name of
barrel medic.
sequences that diverged after
gene duplication [1]. Besides the
initial ambiguity in assigning
homology — two orthologs are
homologous, and two paralogs are
homologous as well — the use of
‘ortholog’ and ‘paralog’ implies
additional probabilistic inferences
about the evolution of the two
sequences being compared [4,5].
Yet further imprecisions often
accrue, because  throughout the
literature the terms ‘ortholog’ and
‘paralog’ are also used to denote
functional similarities between
orthologous genes (e.g., similar
enzymatic activities of their protein
products) and functional
differences between paralogous
genes. Neither of these
relationships, which are often
presumed but not proven, is
implied by the definitions of
‘ortholog’ and ‘paralog’.
To say that the current usage of
‘homologs’, ‘orthologs’ and
‘paralogs’ is complicated and
often less than rigorous would be
understating the case. A
statistically significant similarity is
an experimental fact, whereas
‘homology’, ‘orthology’ and
‘paralogy’ are, in most cases,
hypotheses. There is, at present, a
striking disparity between the
generally high rigor of statistical
methods used to compare
sequences or structures and the
often cavalier, assumption-laden
attitude in the use of ‘homolog’,
‘ortholog’ and ‘paralog’.
To remedy this, I propose two
terms to denote similarity,
‘sequelog’ and ‘spalog’. They
meet the requirement of
evolutionary and functional
neutrality, are mnemonically
helpful, and make it possible to
distinguish through single words
between the realms of similar
sequences and similar 3-D
structures.
The term ‘sequelog’ denotes a
nucleotide or amino acid
sequence that is similar, to a
specified extent, to another
sequence. The term ‘spalog’
(pronounced [spailog]) denotes a
3-D structure that is spatially
similar, to a specified extent, to
another 3-D structure. These
terms are strictly about similarity
and imply nothing about
evolutionary relatedness and
functional properties of the
sequences or structures.
In comparing nucleotide or
amino acid sequences, the extent
of similarity is conveyed by a
numerical score, the percentage of
nucleotide or amino acid positional
identity. Alternatively, the extent of
similarity of two sequences can be
conveyed by the probability of an
identical score for a randomly
chosen pair of sequences of the
same length. In comparing amino
acid sequences, one can also
measure the percentage of
similarity (in contrast to the
percentage of identity). This
includes the identical residues as
well as residues that are scored as
‘similar’ to corresponding residues
of the second sequence, according
to a similarity matrix [2,6].
When the 3-D structures of two
proteins or nucleic acids are
compared, a standard measure of
similarity is the root-mean-square
deviation (r.m.s.d.) between atomic
positions. In principle, one could
introduce the term ‘similog’ to
denote either a sequence or a 3-D
structure that is similar to another
sequence or 3-D structure.
However, the considerable
advantage of ‘sequelog’ and
‘spalog’ is that they instantly define
the nature of similarity (a sequence
or a spatial one), thus obviating
further clarifications.
In a typical usage of the
proposed terms, one can state,
for example, that protein A is a
sequelog of protein B (x% identity
over y residues), or that protein C
is a spalog of protein D (r.m.s.d. of
x Å for y equivalent Cα atoms).
Related measures of spatial
similarity include a Z-score
computed with the program DALI
[7]. To add qualitative, shorthand
distinctions one can state, for
example, that protein A is a weak
but significant sequelog of protein
B (e.g., 24% identity over 165
residues), or that protein C is a
strong spalog of protein D (e.g.,
r.m.s.d. of 2.3 Å for 120 equivalent
Cα atoms), or that protein E is a
strong sequelog of protein F (e.g.,
60% identity over 372 residues). In
using the ‘sequelog’ terminology,
it would be best to invoke just the
percentage of identity of two
sequences and its statistical
significance, which is
straightforwardly computable.
This would avoid the influence of
any other information, for
example, similarity matrices or 3-
D structures. Yet again, the
central idea is to minimize
‘interpretational’ aspects of
‘sequelog’, ‘spalog’ and the
derivative terms, such as
‘sequelogy’, ‘sequelogous’,
‘spalogous’ and so forth.
A strong sequelog of a given
protein is very likely to be its
spalog as well [8], but the
converse is not necessarily true,
as a strong spalog of a given
protein may not be its sequelog.
For example, the 66-residue
Escherichia coli protein ThiS, the
sulfur carrier in the pathway of
thiamine biosynthesis, is a strong
spalog of the 76-residue
eukaryotic ubiquitin (r.m.s.d. of
2.4 Å over 63 equivalent Cα atoms
and a high Z-score of 5.2).
However, it is not a sequelog of
ubiquitin, as the sequence
similarity between the two
proteins (14%) is statistically
insignificant, without additional
information from 3-D structures
[9]. Such comparisons can also
employ the adjectives
‘sequelogous’ or ‘spalogous’. For
example, ‘spalogous’ can be used
to denote similar local 3-D folds in
otherwise dissimilar proteins.
Thus: ‘Although protein A is not a
sequelog of protein B, the 23-127
region of A is strongly spalogous
to the 769-875 region of B
(r.m.s.d. of 2.2 Å over 101
equivalent Cα atoms, and Z-score
of 5.6)’.
To describe a comparison of
sequences or 3-D structures, one
can begin by using ‘sequelog’ and
‘spalog’ or their derivatives in
stating and numerically specifying
the facts of similarity, as
described above. After that, and
only after that, one can
conjecture, if necessary, based on
additional evidence, that the two
sequelogs or spalogs are likely to
be ‘homologs’, ‘orthologs’,
‘paralogs’, or whatever. This way,
the rigorous, numerically explicit
statements about similarities of
specific sequences or 3-D
structures won’t be conjoined, at
birth, with the often unproven
inferences that the latter three
terms inherently imply.
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Spalog, sequelog and terms
derived from them fill an overt
lacuna in the existing terminology.
These terms would clarify and
streamline discourses about
similarity.
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Evidence for a
Hox14 paralog
group in 
vertebrates
Thomas P. Powers and Chris T.
Amemiya*
The genealogy of vertebrate Hox
genes and clusters has long
fascinated evolutionary and
developmental biologists alike.
The importance of Hox genes is
underscored by their involvement
in axial patterning, their spatial
colinearity of gene order with
respect to expression domains
and their likely interconnection
with morphological evolution [1].
Whereas the protovertebrate
amphioxus possesses a group 14
gene at the 5′-end of its
‘archetypal’ Hox cluster
(AmphiHox14) [2,3], such a group
14 gene has thus far not been
identified in any vertebrate. Based
on these observations, the
ancestral condition for the jawed
vertebrates (gnathostomes) has
been inferred to consist of 13
paralogous groups of Hox genes.
According to this scenario, the
Hox14 gene of amphioxus would
have originated by tandem
duplication of a posterior Hox
gene in this lineage [3].
Sequence analysis of the HoxA
cluster of the Indonesian
coelacanth (Latimeria
menadoensis) and the HoxD
cluster of the horn shark
(Heterodontus francisci) revealed
in each case an additional Hox
gene between the group 13 gene
and the even-skipped (Evx)
ortholog (Figure 1A). These
additional genes have the same
transcriptional orientation as the
other Hox genes in the cluster, but
the opposite orientation to the Evx
gene. Hoxa14 and Hoxd14 encode
predicted proteins of 232 and 266
amino acids, respectively (Figure
1B). Moreover, these Hox14 genes
possess ‘split’ homeoboxes and
show exon-intron boundaries at
identical positions as dipteran
Abdominal-B genes and two of the
‘posterior’ Hox genes in
amphioxus, including AmphiHox14
[3]. These positions are different
from those in the Evx genes, which
also possess split homeoboxes;
this further confirms that the
Hox14 genes are not duplicated
Evx orthologs. In addition, a
Hoxa14 pseudogene was found
upstream of the Hoxa13 gene in
the horn shark. The exon structure
of this pseudogene is similar to
that of the Hoxa14 and Hoxd14
genes of the coelacanth and the
horn shark, respectively (Figure 1A,
and supplemental data). No other
Hox14 genes were identified in
surveys of the GenBank database.
In order to test the relationship
of Hox14 genes to other posterior
Hox genes, we constructed
phylogenetic trees using amino
acid sequences of the
homeodomains as well as the
complete proteins. Figure 1C
shows a phylogenetic tree based
on the homeodomains of horn
shark Hoxd14 and coelacanth
Hoxa14 with those of vertebrate
group 13 and amphioxus Hox13
and Hox14. Regardless of the
phylogenetic method, all trees
yield similar topologies and show a
strong relationship of the two
vertebrate Hox14 sequences to
one another, but not to other
posterior Hox genes or to any
amphioxus sequences (Figure 1C,
and supplemental data). This latter
point raises questions as to the
orthology of the AmphiHox14 and
gnathostome Hox14 genes,
despite similar genomic structure
and similar location within the
respective clusters. However, the
substantial amount of time that has
passed since the divergence of
amphioxus and gnathostomes (>
600 mya [4]), and the accelerated
rate of molecular evolution of
‘posterior’ Hox genes may obscure
a meaningful phylogenetic signal
between vertebrate and
amphioxus genes, thereby
rendering such analyses
problematic [3].
The shared identity between
shark Hoxd14 and coelacanth
Hoxa14 is emphasized by the
partial alignment in Figure 1D. The
high degree of relatedness has
been retained despite involving
two separate Hox clusters (A and
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